Skip to main content

Chronic Heart Failure- AMGEN 20110203

The purpose of this study is to reduce the risk of cardiovascular death or heart failure in patients with reduced ejection fraction (GALACTIC-HF).

Sponsor: AMGEN

Phase: 3

Indication: Heart Failure

Age:  ≥ 18 to ≤ 85 years of age

Category: Treatment

For more information:




Studies Currently Available At

Sign Up For This Study